Related references
Note: Only part of the references are listed.International Consensus Guidelines for the Optimal Use of the Polymyxins Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Brian T. Tsuji et al.
PHARMACOTHERAPY (2019)
Antimicrobial Resistance or Delayed Appropriate Therapy-Does One Influence Outcomes More Than the Other Among Patients With Serious Infections Due to Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacteriaceae?
Thomas P. Lodise et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Pharmacodynamics of minocycline against Acinetobacter baumannii studied in a pharmacokinetic model of infection
Wadha A. Alfouzan et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
High-Dose Ampicillin-Sulbactam Combinations Combat Polymyxin-Resistant Acinetobacter baumannii in a Hollow-Fiber Infection Model
Justin R. Lenhard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii
Brian T. Tsuji et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Molecular Mechanisms of Sulbactam Antibacterial Activity and Resistance Determinants in Acinetobacter baumannii
William F. Penwell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Activity of Daptomycin or Linezolid in Combination with Rifampin or Gentamicin against Biofilm-Forming Enterococcus faecalis or E. faecium in an In Vitro Pharmacodynamic Model Using Simulated Endocardial Vegetations and an In Vivo Survival Assay Using Galleria mellonella Larvae
Megan K. Luther et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Bad Bugs Need Old Drugs: A Stewardship Program's Evaluation of Minocycline for Multidrug-Resistant Acinetobacter baumannii Infections
Debra A. Goff et al.
CLINICAL INFECTIOUS DISEASES (2014)
A Review of Intravenous Minocycline for Treatment of Multidrug-Resistant Acinetobacter Infections
David J. Ritchie et al.
CLINICAL INFECTIOUS DISEASES (2014)
Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis
E. V. Lemos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Pharmacokinetic/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models
Yuta Yokoyama et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Comparison of ML8-X10 (a prototype oil-in-water micro-emulsion based on a novel free fatty acid), taurolidine/citrate/heparin and vancomycin/heparin antimicrobial lock solutions in the eradication of biofilm-producing staphylococci from central venous catheters
Megan K. Luther et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Pharmacodynamics Modeling To Optimize Dosage Regimens of Sulbactam
Sutep Jaruratanasirikul et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia
Shih-Tse Huang et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2012)
Outbreak of Colistin-Resistant, Carbapenem-Resistant Klebsiella pneumoniae in Metropolitan Detroit, Michigan
Dror Marchaim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Evaluation of Ceftaroline Activity versus Daptomycin (DAP) against DAP-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strains in an In Vitro Pharmacokinetic/Pharmacodynamic Model
Molly Steed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
In vitro activity of tigecycline in combination with gentamicin against biofilm-forming Staphylococcus aureus
Kevin W. McConeghy et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Minocycline to Improve Neurologic Outcome in Stroke (MINOS) A Dose-Finding Study
Susan C. Fagan et al.
STROKE (2010)
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution
Jason A. Roberts et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients
Alexandre P. Zavascki et al.
CLINICAL INFECTIOUS DISEASES (2008)
Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?
Jason A. Roberts et al.
CURRENT OPINION IN CRITICAL CARE (2008)
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections
Drosos E. Karageorgopoulos et al.
LANCET INFECTIOUS DISEASES (2008)
Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii
Jian Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model
KL LaPlante et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies
Matthew E. Falagas et al.
CRITICAL CARE (2006)
Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa
VH Tam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study
H Wisplinghoff et al.
CLINICAL INFECTIOUS DISEASES (2004)
Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model
KL LaPlante et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Share Paper
